{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:59:18Z","timestamp":1789999158460,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019065","name":"Tianjin Science and Technology Program","doi-asserted-by":"publisher","award":["21JCQNJC01350"],"award-info":[{"award-number":["21JCQNJC01350"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.colsurfb.2024.114310","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T18:01:35Z","timestamp":1728496895000},"page":"114310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Breast cancer-targeted therapy and doxorubicin multidrug resistance are reversed via macrophage membrane-camouflaged liposomes"],"prefix":"10.1016","volume":"245","author":[{"given":"Yuting","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuchao","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanlian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoliang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2024.114310_bib1","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.2147\/OTT.S174329","article-title":"CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer","author":"Wang","year":"2018","journal-title":"OncoTargets Ther."},{"issue":"3","key":"10.1016\/j.colsurfb.2024.114310_bib2","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/tbj.13526","article-title":"The ongoing evaluation and evolution of breast cancer surgical care[J]","volume":"26","author":"Ferstenberg","year":"2020","journal-title":"Breast J."},{"key":"10.1016\/j.colsurfb.2024.114310_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114505","article-title":"Dual-drug codelivery nanosystems: An emerging approach for overcoming cancer multidrug resistance","volume":"161","author":"Gong","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.colsurfb.2024.114310_bib4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2019.04.020","article-title":"Immunological consequences of chemotherapy: Single drugs, combination therapies and nanoparticle-based treatments","volume":"305","author":"Pusuluri","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2024.114310_bib5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jconrel.2023.03.038","article-title":"Membrane fusion-mediated delivery of small-molecule HER2 tyrosine kinase inhibitor for effective tumor chemosensitization","volume":"357","author":"Hao","year":"2023","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.colsurfb.2024.114310_bib6","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1002\/ptr.6694","article-title":"Application of curcumin and its derivatives in tumor multidrug resistance","volume":"34","author":"Xu","year":"2020","journal-title":"Phytother. Res."},{"issue":"7","key":"10.1016\/j.colsurfb.2024.114310_bib7","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1002\/ptr.7096","article-title":"The effects and mechanisms of aloe-emodin on reversing adriamycin-induced resistance of MCF-7\/ADR cells.","volume":"35","author":"Cheng","year":"2021","journal-title":"Phytother. Res."},{"issue":"03","key":"10.1016\/j.colsurfb.2024.114310_bib8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1142\/S0192415X23500283","article-title":"Research progress of traditional Chinese medicine monomers in reversing multidrug resistance of breast cancer","volume":"51","author":"Wang","year":"2023","journal-title":"Am. J. Chin. Med."},{"issue":"8-9","key":"10.1016\/j.colsurfb.2024.114310_bib9","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.phymed.2014.04.029","article-title":"Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells","volume":"21","author":"Sun","year":"2014","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114310_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/10717544.2019.1573861","article-title":"Study on preparation, characterization and multidrug resistance reversal of red blood cell membrane-camouflaged tetrandrine-loaded PLGA nanoparticles","volume":"26","author":"Que","year":"2019","journal-title":"Drug Deliv."},{"key":"10.1016\/j.colsurfb.2024.114310_bib11","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00280-007-0420-0","article-title":"Tetrandrine achieved plasma concentrations capable of reversing MDR in vitro and had no apparent effect on doxorubicin pharmacokinetics in mice","volume":"60","author":"Dai","year":"2007","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"8-9","key":"10.1016\/j.colsurfb.2024.114310_bib12","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.phymed.2014.04.029","article-title":"Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells","volume":"21","author":"Sun","year":"2014","journal-title":"Phytomedicine"},{"issue":"7","key":"10.1016\/j.colsurfb.2024.114310_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1208\/s12249-023-02630-8","article-title":"A (traditional Chinese medicine) TCM-inspired doxorubicin resistance reversing strategy: preparation, characterization, and application of a Co-loaded pH-sensitive liposome","volume":"24","author":"Zhang","year":"2023","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1016\/j.colsurfb.2024.114310_bib14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/vaccines9040359","article-title":"Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 vaccines","volume":"9","author":"Thi","year":"2021","journal-title":"Vaccines"},{"issue":"7","key":"10.1016\/j.colsurfb.2024.114310_bib15","first-page":"5510","article-title":"Bioactive ceria nanoenzymes target mitochondria in reperfusion injury to treat ischemic stroke","volume":"18","author":"Liao","year":"2024","journal-title":"ACS nano"},{"issue":"9","key":"10.1016\/j.colsurfb.2024.114310_bib16","doi-asserted-by":"crossref","first-page":"7922","DOI":"10.3390\/ijms24097922","article-title":"Theranostics nanomedicine applications for colorectal cancer and metastasis: recent advances","volume":"24","author":"Kasi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114310_bib17","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1038\/s41598-020-61726-4","article-title":"Carbon nanoparticles-decorated carbon nanotubes","volume":"10","author":"Awadallah-f","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.colsurfb.2024.114310_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejpb.2019.08.015","article-title":"Recent advances in non-ionic surfactant vesicles (niosomes): Fabrication, characterization, pharmaceutical and cosmetic applications","volume":"144","author":"Chen","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"12","key":"10.1016\/j.colsurfb.2024.114310_bib19","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.3390\/ijms23126858","article-title":"Nano\u2013liposomes double loaded with curcumin and tetrandrine: Preparation, characterization, hepatotoxicity and anti\u2013tumor effects.","volume":"23","author":"Song","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2024.114310_bib20","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2147\/IJN.S228715","article-title":"Preparation, characterization, and pharmacokinetic study of a novel long-acting targeted paclitaxel liposome with antitumor activity","author":"Han","year":"2020","journal-title":"Int. J. Nanomed."},{"issue":"10","key":"10.1016\/j.colsurfb.2024.114310_bib21","doi-asserted-by":"crossref","first-page":"12281","DOI":"10.1021\/acsnano.9b09713","article-title":"What went wrong with anticancer nanomedicine design and how to make it right","volume":"14","author":"Sun","year":"2020","journal-title":"ACS nano"},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114310_bib22","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1080\/10717544.2021.1938757","article-title":"Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles","volume":"28","author":"Li","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.colsurfb.2024.114310_bib23","doi-asserted-by":"crossref","first-page":"2402445","DOI":"10.1002\/adma.202402445","article-title":"Revolutionizing neurocare: biomimetic nanodelivery via cell membranes","author":"Liao","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.colsurfb.2024.114310_bib24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2022.04.019","article-title":"Advancements in cell membrane camouflaged nanoparticles: a bioinspired platform for cancer therapy","volume":"346","author":"Dhas","year":"2022","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.colsurfb.2024.114310_bib25","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1021\/acsnano.2c11965","article-title":"Advances in drug delivery systems based on red blood cells and their membrane-derived nanoparticles","volume":"17","author":"Nguyen","year":"2023","journal-title":"ACS nano"},{"key":"10.1016\/j.colsurfb.2024.114310_bib26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jconrel.2020.05.016","article-title":"Platelet membrane-cloaked paclitaxel-nanocrystals augment postoperative chemotherapeutical efficacy","volume":"324","author":"Mei","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2024.114310_bib27","first-page":"80","article-title":"Engineering white blood cell membrane-camouflaged nanocarriers for inflammation-related therapeutics","volume":"23","author":"Song","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.colsurfb.2024.114310_bib28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jconrel.2023.05.009","article-title":"Recent advances in biomimetic nanodelivery systems: new brain-targeting strategies","volume":"358","author":"Liao","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2024.114310_bib29","first-page":"221","article-title":"Tumor cell membrane-camouflaged responsive nanoparticles enable MRI-guided immuno-chemodynamic therapy of orthotopic osteosarcoma","volume":"17","author":"Fu","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.colsurfb.2024.114310_bib30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jconrel.2024.03.055","article-title":"All-stage targeted red blood cell membrane-coated docetaxel nanocrystals for glioma treatment","volume":"369","author":"Ding","year":"2024","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114310_bib31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/ijms19010092","article-title":"The phagocytic function of macrophage-enforcing innate immunity and tissue homeostasis","volume":"19","author":"Hirayama","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2024.114310_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-019-0568-z","article-title":"Tumor-associated macrophages: an accomplice in solid tumor progression","volume":"26","author":"Chen","year":"2019","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114310_bib33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","article-title":"Macrophages and metabolism in the tumor microenvironment","volume":"30","author":"Vitale","year":"2019","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.colsurfb.2024.114310_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2021.151153","article-title":"The role of macrophage in regulating tumour microenvironment and the strategies for reprogramming tumour-associated macrophages in antitumour therapy","volume":"100","author":"Xu","year":"2021","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.colsurfb.2024.114310_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122872","article-title":"Cannabidiol\u2013loaded biomimetic macrophage membrane vesicles against post\u2013traumatic stress disorder assisted by ultrasound.","volume":"637","author":"Li","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.colsurfb.2024.114310_bib36","doi-asserted-by":"crossref","first-page":"2200289","DOI":"10.1002\/smtd.202200289","article-title":"Macrophage cell membrane-cloaked nanoplatforms for biomedical applications.","volume":"6","author":"Lopes","year":"2022","journal-title":"Small Methods"},{"key":"10.1016\/j.colsurfb.2024.114310_bib37","article-title":"Construction of bionic nanoparticles camouflaged with macrophage membranes for drug delivery in breast cancer","volume":"84","author":"Yan","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114310_bib38","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/s12951-022-01746-6","article-title":"Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment","volume":"20","author":"Wu","year":"2022","journal-title":"J. nanobiotechnology"}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776524005691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776524005691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T16:11:47Z","timestamp":1732896707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776524005691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":38,"alternative-id":["S0927776524005691"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2024.114310","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast cancer-targeted therapy and doxorubicin multidrug resistance are reversed via macrophage membrane-camouflaged liposomes","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2024.114310","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114310"}}